Lumos Pharma Inc (LUMO)
2.39
-0.10
(-4.02%)
USD |
NASDAQ |
Jun 14, 16:00
2.39
0.00 (0.00%)
After-Hours: 20:00
Lumos Pharma Revenue (Annual): 2.051M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.051M |
| December 31, 2022 | 1.523M |
| December 31, 2021 | 0.23M |
| December 31, 2020 | 0.168M |
| December 31, 2019 | |
| December 31, 2018 | 12.47M |
| December 31, 2017 | 28.71M |
| December 31, 2016 | 35.77M |
| Date | Value |
|---|---|
| December 31, 2015 | 68.50M |
| December 31, 2014 | 172.59M |
| December 31, 2013 | 1.093M |
| December 31, 2012 | 1.687M |
| December 31, 2011 | 1.872M |
| December 31, 2010 | |
| December 31, 2009 | 0.934M |
| December 31, 2008 | 0.633M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.168M
Minimum
2020
2.051M
Maximum
2023
0.993M
Average
0.8765M
Median
Revenue (Annual) Benchmarks
| icad Inc | 17.32M |
| Perspective Therapeutics Inc | -- |
| Palatin Technologies Inc | 4.854M |
| Bio-Path Holdings Inc | -- |
| PDS Biotechnology Corp | -- |